Anton Paige E, Maphis Nicole M, Linsenbardt David N, Coleman Leon G
Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Adv Exp Med Biol. 2025;1473:211-242. doi: 10.1007/978-3-031-81908-7_10.
Alcohol use has recently emerged as a modifiable risk factor for Alzheimer's disease (AD). However, the neurobiological mechanisms by which alcohol interacts with AD pathogenesis remain poorly understood. In this chapter, we review the epidemiological and preclinical support for the interaction between alcohol use and AD. We hypothesize that alcohol use increases the rate of accumulation of specific AD-relevant pathologies during the prodromal phase and exacerbates dementia onset and progression. We find that alcohol consumption rates are increasing in adolescence, middle age, and aging populations. In tandem, rates of AD are also on the rise, potentially as a result of this increased alcohol use throughout the lifespan. We then review the biological processes in common between alcohol use disorder and AD as a means to uncover potential mechanisms by which they interact; these include oxidative stress, neuroimmune function, metabolism, pathogenic tauopathy development and spread, and neuronal excitatory/inhibitory balance (EIB). Finally, we provide some forward-thinking suggestions we believe this field should consider. In particular, the inclusion of alcohol use assessments in longitudinal studies of AD and more preclinical studies on alcohol's impacts using better animal models of late-onset Alzheimer's disease (LOAD).
饮酒最近已成为阿尔茨海默病(AD)一个可改变的风险因素。然而,酒精与AD发病机制相互作用的神经生物学机制仍知之甚少。在本章中,我们综述了饮酒与AD之间相互作用的流行病学和临床前证据。我们假设,饮酒会在前驱期增加特定AD相关病理的累积速率,并加剧痴呆症的发作和进展。我们发现,青少年、中年和老年人群的饮酒率正在上升。与此同时,AD的发病率也在上升,这可能是由于一生中饮酒量增加所致。然后,我们回顾了酒精使用障碍和AD之间共有的生物学过程,以此作为揭示它们相互作用潜在机制的一种手段;这些过程包括氧化应激、神经免疫功能、代谢、致病性tau病变的发展和传播,以及神经元兴奋/抑制平衡(EIB)。最后,我们提出了一些前瞻性建议,我们认为该领域应予以考虑。特别是,在AD纵向研究中纳入饮酒评估,以及使用更好的晚发性阿尔茨海默病(LOAD)动物模型进行更多关于酒精影响的临床前研究。